BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33812429)

  • 1. [Clinical Characteristics and Survival Analysis of Patients with IgD Multiple Myeloma].
    Gao XY; Ma YP; Chao Y; Fan L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):547-552. PubMed ID: 33812429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and therapeutic efficacy of immunoglobin D multiple myeloma].
    Liu Y; Ke XY; Wang J; Jing HM; Wang JJ; Dong F; Wan WL; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1628-32. PubMed ID: 25543487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation].
    Huang WY; Zou DH; Liu W; An G; Xu Y; Sui WW; Deng SH; Li CW; Liu H; Li J; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):496-500. PubMed ID: 30032568
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and prognostic factors of induction therapy combined with autologous stem cell transplantation in 201 patients with multiple myeloma].
    Jin L; Fu W; Xi H; Zhang C; Du J; He H; Jiang H; Zeng T; Fan J; Zhou L; Chang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):14-9. PubMed ID: 26876247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of newly diagnosed multiple myeloma patients with renal dysfunction].
    Zhu W; Lu J; Lu J; Hou J; Huang X; Chen W
    Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):741-4. PubMed ID: 26080844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Analysis of 46 Cases of Multiple Myeloma with Extramedullary Disease].
    Chao Y; Fan L; Gao XY; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):115-121. PubMed ID: 33554807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era.
    Chen L; Fan F; Deng J; Xu J; Xu A; Sun C; Hu Y
    Ann Hematol; 2019 Apr; 98(4):963-970. PubMed ID: 30610280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Features and Response to Treatment in Newly Diagnosed Multiple Myeloma Patients with Deletion 17P].
    Liu Y; Ke XY; Wang J; Wang YF; Dong F; Tian L; Wan W; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):802-806. PubMed ID: 28641639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
    Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
    Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation and outcomes of patients with multiple myeloma harboring gain or amplification of 1q21 and receiving novel agent therapies: results from a single-center study.
    Chen H; Zhou N; Shi H; Yu W; Wu L; Zhou F
    Hematology; 2023 Dec; 28(1):2177979. PubMed ID: 36794720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of serum IgD quantitation for evaluation of clinical efficacy in IgD multiple myeloma].
    He J; Zhang H; Jiang H; Zeng T; Chang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):288-91. PubMed ID: 27093990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].
    Wang XX; Zhang LL; Wang T; Hou JX; Wang ZT; Qin H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):777-782. PubMed ID: 37356939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of the efficacy and influencing factors of autologous hematopoietic stem cell transplantation for multiple myeloma.
    Zhang BL; Zhou J; Lin QD; Liu YZ; Zhang YL; Gui RR; Song YP; Fang BJ
    Artif Organs; 2019 Oct; 43(10):1028-1034. PubMed ID: 30972806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.
    Bladé J; Lust JA; Kyle RA
    J Clin Oncol; 1994 Nov; 12(11):2398-404. PubMed ID: 7964956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and Influencing Factors of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Retrospective Analysis].
    Zhang BL; Zhou J; Zhang GL; Gui RR; Lin QD; Zu YL; Yu FC; Zhao HF; Li Z; Wang J; Fu YW; Zhang LN; Zhou H; Fang BJ; Song YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1414-1419. PubMed ID: 30295260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective multi-center trial of non-interventional and observational study of lenalidomide in Chinese patients with multiple myeloma].
    Wang GM; Yang GZ; Huang ZX; Zhong YP; Jin FY; Liao AJ; Wang XM; Fu ZZ; Liu H; Li XL; Zhou JF; Zhang X; Hu Y; Meng FY; Huang XJ; Chen WM; Lu J
    Zhonghua Nei Ke Za Zhi; 2017 Jul; 56(7):500-506. PubMed ID: 28693058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.